Pomegranate in Breast Cancer:

A Comprehensive Review of its Therapeutic Potential

 

Kanchan Rajendra Pawar

Shantiniketan College of Pharmacy, Dhotre, Maharashtra, India.

*Corresponding Author E-mail: pawark200435@gmail.com

 

Abstract:

Punica granatum L., commonly known as the pomegranate, is a fruit-bearing plant native to Iran and belonging to the Punicaceae family. Characterized by its large, globular berries containing numerous seeds enveloped in a juicy, edible pulp, pomegranate has been employed for centuries in various cultures to prevent and treat a multitude of health disorders, including inflammation, diabetes, diarrhea, dysentery, and dental plaque. Aim of the Review: This review aims to provide an up-to-date, comprehensive overview of the chemical constituents, traditional uses, phytochemistry, pharmacology, and toxicology of Punica granatum L. Specifically, this review focuses on the potential exploitation of this species to treat diverse diseases and suggests future investigations. The increasing demand for complementary medicine has driven the search for effective alternative therapies that minimize adverse effects associated with conventional drugs. Pomegranate has garnered significant attention due to its remarkable nutritional and medicinal properties. In Mexico, the harvest and consumption of pomegranate have surged, driven by recent discoveries of phytochemical compounds exhibiting antioxidant, anti-inflammatory, and antiviral activities, with promising applications in the food industry.

 

KEYWORDS: Pomegranate, Antioxidant, Anti-inflammatory.

 

 


INTRODUCTION:

Pomegranate (Punica granatum) is a tree belonging to the Punicaceae family with a height around 3 to 6 m. Pomegranates are one of the oldest edible fruits, originating in Central Asia. It has rounded fruit with a dry outer covering (husk) made up of two layers: (1) a hard-outer layer called an epicarp, (2) a soft inner layer called a mesocarp.1 The inner mesocarp has distinct chambers that contain fleshy seeds.2

 

This plant's leaves are bright green, elongated, smooth, shiny, and slightly wavy. The flowers are notable for their flared shape and bright orange petals, usually numbering 5 to 8.3

 

Approximately 26-30% of the pomegranate's total weight is comprised of peels, which are rich in phenolic compounds.4 This includes flavonoids, such as anthocyanins, catechins, and complex flavonoids, as well as hydrolyzable tannins like punicalin, and ellagic acid, all of which are highly concentrated in pomegranate peel and juice.5

 

The principal constituents of pomegranate arils include 85% water, 10% total sugars (mainly fructose and glucose), and 1.5% pectin. Furthermore, arils contain organic acids like ascorbic acid, citric acid, and malic acid, as well as bioactive phenolics and flavonoids, with anthocyanins being the primary flavonoid.6

 

 

 

 

 

Fig. 1: A) Pomegranate fruit, B) pomegranate peel powder, C) pomegranate seeds D) sundried pomegranate peel.

 

Pomegranates are a nutrient-rich fruit, boasting an array of bioactive compounds, including anthocyanins, flavonoids, tannins, phenolics, proanthocyanidins, sterols, terpenes, and terpenoids. Additionally, they contain organic acids (ascorbic, citric, and malic), sugars (fructose and glucose), pectin, and fatty acids in their seeds. Pomegranates are also a good source of minerals like iron, copper, sodium, magnesium, and zinc.7

 

Traditional medicinal uses: Pomegranate peel has been traditionally used to address various health concerns.8 Its aqueous extract, obtained by boiling for 10-40 minutes, treats diarrhea, dysentery, dental plaque, and is used as a douche and enema agent.9 Topical application of PoP powder heals bleeding gums and plaque in periodontitis patients. Additionally, PoP is gargled to relieve sore throats and hoarseness.10 In the Indian Subcontinent, dried PoP, bark, and flower infusions treat diarrhea, intestinal worms, nosebleeds, and ulcers. Hyperacidity is treated with 5-10g of peel powder taken orally two to three times daily.11

·       Relieves symptoms of anemia.12

·       Lower risk of heart attacks and strokes.13

·       Reduces risk of developing cancer.

·       Lowers dental plaque.

·       Helps overcome depression.

·       Rich in antioxidants.

·       Packed with anti-ageing properties.14,15,16

 

 

Fig. 2: Benefits of Pomegranates.

Cultivation of pomegranate:

 

 

Table 1: fraction composition of Punica granatum fruit.

Constituents

Concentration

Water (g)

82.5

Food fiber (g)

3.1

Protein (g)

0.7

Lipids (g)

0.6

Carbohydrates(g)

16.7

Fructose

7.9

Sucrose

1

Minerals (mg) 

Sodium

7

Potassium

290

Calcium

8

Magnesium

3

Phosphorus

17

Iron

0.5

Vitamins (mg) 

Thiamine

0.05

Riboflavin

0.02

Ascorbic acid

7

Organics acid (g)

0.77

Malic acid

0.1

Citric acide

0.5

 

Phytochemistry of Pomegranate:

Major Phytoconstituents:

·       Ellagic Acid

·       Flavonoids

·       Phenolic Acid (gallic, ferulic)

·       Tannins

·       Terpenes

Other Bioactive Compounds:

·       Alkaloids (Pomegranatin)

·       Glycosides

·       Saponins

·       Sterols (beta-sitosterol)

·       Fatty acid (oleic)

·       Vitamins (C, E, K)

·       Minerals (potassium, Mg)20,21

 

Pharmacological Mechanisms:

1.     Anticancer activity: Inducing apoptosis, inhibiting cell proliferation.

2.     Cardiovascular protection: Improving lipid profiles, reducing blood pressure.

3.     Anti-inflammatory activity: Inhibiting pro-inflammatory cytokines, enzymes.

4.     Antioxidant activity: Scavenging free radicals, reducing oxidative stress.22

 

Pharmacokinetics:

1. Distribution: Wide distribution, including brain, heart, liver.

2. Metabolism: Hepatic metabolism, primarily through CYP3A4.

3. Excretion: Renal excretion, fecal elimination.

4. Absorption: Bioactive compounds absorbed through gut, skin.23

 

Therapeutic Applications:

1. Neurodegenerative disease management.

2. Anti-inflammatory and antimicrobial applications.

3. Cardiovascular disease prevention.

4. Cancer prevention and treatment.24

Pomegranate is a rich source of bioactive compounds, including ellagic acid, punicalagins, and anthocyanins. These compounds have been shown to possess anti-proliferative, anti-inflammatory, and pro-apoptotic effects.25

 

Anti-Cancer Mechanisms:

1.     Inhibition of cell proliferation and induction of apoptosis

2.     Anti-angiogenic effects

3.     Inhibition of cancer cell invasion and metastasis

4.     Modulation of signaling pathways (e.g., NF-κB, PI3K/Akt)26

 

Anti-Cancer Efficacy:

1. Prostate cancer: Inhibition of tumor growth and reduction of PSA levels

2. Breast cancer: Inhibition of tumor growth and induction of apoptosis

3. Colon cancer: Inhibition of tumor growth and reduction of inflammation

4. Lung cancer: Inhibition of tumor growth and induction of apoptosis.27

 

Breast Cancer:

 

Fig. 3: Anti-Cancer Mechanism of Punica granatum and molecular targets.

MATERIALS AND METHODS:

Breast cancer's increasing global burden and the expanding evidence on natural compounds' benefits motivated this literature review on Punica granatum's (pomegranate) anti-cancer properties.

 

Chemoprevention:

1.     Pomegranate extract supplements

2.     Ellagic acid (EA) and punicalagins (PC) extracts

3.     Pomegranate juice consumption.29

 

Therapeutic approaches:

1.     Combination therapy with conventional treatments (e.g., chemotherapy, hormone therapy)

2.     Targeting specific breast cancer subtypes (e.g., ER+, HER2+)

3.     Inhibition of cancer stem cells and metastasis.30

 

Consistent with previous findings, treatment of human breast cancer cells with pomegranate extract led to dose-dependent growth inhibition and cytotoxicity. This outcome aligns with another study demonstrating that pomegranate seed extract decreased viability and hindered growth of human breast cancer cells.31

 

CONCLUSION:

Our study demonstrates significant antiproliferative and pro-apoptotic effects on breast cancer cells, highlighting the potential of [Substance/Method] as a therapeutic strategy against breast cancer. These findings warrant further investigation for clinical applications.

 

This review highlights the potential of pomegranate as a novel adjunctive treatment for breast cancer, demonstrating anti-proliferative, anti-inflammatory, and pro-apoptotic effects.

 

REFERENCE:

1.      Holland D, Bar-Ya’akov I. Pomegranate (Punica granatum L.) breeding. Advances in Plant Breeding Strategies: Fruits. 2018; 3: 601-47.

2.      Pellow BJ, Henwood MJ, Carolin RC. Flora of the Sydney region: a complete revision. Sydney University Press; 2009.

3.      Ganapathy M. Campus. Forestry. 36: 454-89.

4.      Mellado-Negrete A, Peña-Vázquez GI, Urías-Orona V, De La Garza AL. Polyphenol bioaccessibility and antioxidant activity of pomegranate (Punica granatum) peel supplementation in diet-induced obese rats. Journal of Medicinal Food. 2023 Aug 1; 26(8): 570-9.

5.      Sharma J, Maity A. Pomegranate phytochemicals: Nutraceutical and therapeutic values. Fruit Veg. Cereal Sci. Biotech. 2010; 4: 56-76.

6.      Mokapane FM. Effects of pre-treatments to preserve quality attributes and prolong shelf-life of dried pomegranate arils (Doctoral dissertation, Stellenbosch: Stellenbosch University).

7.      Alamgir AN, Alamgir AN. Vitamins, nutraceuticals, food additives, enzymes, anesthetic aids, and cosmetics. Therapeutic Use of Medicinal Plants and their Extracts: Volume 2: Phytochemistry and Bioactive Compounds. 2018:407-534.

8.      Rebelo JM. Impact of the use of an educational Web-Application on nutritional knowledge and food consumption in children and adolescents with overweight or obesity.

9.      Athmaselvi KA, Kumar C, Poojitha P. Interventions of Ohmic Heating Technology in Foods. State-of-the-Art Technologies in Food Science: Human Health, Emerging Issues and Specialty Topics. 2018 Aug 14:321.

10.   Rahman MM. Medicinal Plants Used as an Alternative to Treat Gingivitis and Periodontitis.

11.   Muni W. An Eight-hundred-Year-Old Book of Indian Medicine and Formulas. Asian Educational Services; 1992.

12.   Bokemeyer C, Foubert J. Anemia impact and management: focus on patient needs and the use of erythropoietic agents. In Seminars in Oncology 2004 Jun 1 (Vol. 31, pp. 4-11). WB Saunders.

13.   Della Sopravvivenza Nell’infarto S. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. JAMA. 2005; 293: 427-36.

14.   Friedlander AH, Mahler ME. Major depressive disorder: psychopathology, medical management and dental implications. The Journal of the American Dental Association. 2001 May 1; 132(5): 629-38.

15.   Milner JA. Reducing the risk of cancer. In Functional foods: Designer foods, pharmafoods, nutraceuticals 1994 (pp. 39-70). Boston, MA: Springer US.

16.   Liu M, Chen S, Zhang Z, Li H, Sun G, Yin N, Wen J. Anti-ageing peptides and proteins for topical applications: A review. Pharmaceutical Development and Technology. 2022 Jan 2; 27(1): 108-25.

17.   Aher YL, Rahane S. A review of pomegranate cultivation. Int Res J Eng Tech. 2016; 3(4): 2083-8.

18.   Kandylis P, Kokkinomagoulos E. Food applications and potential health benefits of pomegranate and its derivatives. Foods. 2020 Jan 23; 9(2): 122.

19.   Valero-Mendoza AG, Meléndez-Rentería NP, Chávez-González ML, Flores-Gallegos AC, Wong-Paz JE, Govea-Salas M, Zugasti-Cruz A, Ascacio-Valdés JA. The whole pomegranate (Punica granatum. L), biological properties and important findings: A review. Food Chemistry Advances. 2023 Oct 1; 2: 100153.

20.   Bishayee A, Thoppil RJ, Darvesh AS, Ohanyan V, Meszaros JG, Bhatia D. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis. The Journal of nutritional biochemistry. 2013 Jan 1; 24(1): 178-87.

21.   Pande SD, Wagh AS, Bhagure LB, Patil SG, Deshmukh AR. Preparation and evaluation of phytosomes of pomegrane peels. Research Journal of Pharmacy and Technology. 2015;8(4):416-22.

22.   Alabsi AM, Ali R, Ali AM, Al-Dubai SA, Harun H, Abu Kasim NH, Alsalahi A. Apoptosis induction, cell cycle arrest and in vitro anticancer activity of gonothalamin in a cancer cell lines. Asian Pacific Journal of Cancer Prevention. 2012; 13(10): 5131-6.

23.   Riaz S, Rasul A, Ahmad M, Asrar M, Hassan M. Pomegranate Peel Extract as 6-Phosphogluconate Dehydrogenase (6PGD) Inhibitor for Treatment of Breast Cancer. Cell Biochemistry and Biophysics. 2024 Sep 5: 1-7.

24.   Krishna Bayineni V, Naira VR, Kadeppagari RK. Biomedical Applications of Nanozymes: Disease Diagnosis and Therapy. InHandbook of Consumer Nanoproducts 2022 May 6 (pp. 675-687). Singapore: Springer Nature Singapore.

25.   Syed D, Malik A, Hadi N, Schmitt C, Afaq F, Mukhtar H. Molecular mechanisms of chemoprevention of cancer by pomegranate. In Pomegranates. 2006 Jul 7 (pp. 135-150). CRC Press.

26.   Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduction and Targeted Therapy. 2023 May 11; 8(1): 198.

27.   Lokeshwar BL. MMP inhibition in prostate cancer. Annals of the New York Academy of Sciences. 1999 Jun; 878(1): 271-89.

28.   Banerjee N. Polyphenol-induced Anti-inflammatory and Cytotoxic Activities in Breast and Colon Cancer: Potential Role of miRNA's in Cell Survival and Inflammation (Doctoral dissertation).

29.   Yang X, Niu Z, Wang X, Lu X, Sun J, Carpena M, Prieto MA, Simal-Gandara J, Xiao J, Liu C, Li N. The nutritional and bioactive components, potential health function and comprehensive utilization of pomegranate: a review. Food Reviews International. 2023 Oct 3; 39(9): 6420-46.

30.   Zeng X, Liu C, Yao J, Wan H, Wan G, Li Y, Chen N. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications. Pharmacological Research. 2021 Jan 1; 163: 105320.

31.   Jeune ML, Kumi-Diaka J, Brown J. Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. Journal of medicinal food. 2005 Dec 1; 8(4): 469-75.

 

 

 

 

Received on 09.10.2024      Revised on 12.11.2024

Accepted on 03.12.2024      Published on 10.03.2025

Available online from March 21, 2025

Research J. Science and Tech. 2025; 17(1):35-40.

DOI: 10.52711/2349-2988.2025.00005

 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.